Keros Therapeutics, Inc. (KROS) has 12 identified peers for comparison in the Healthcare sector. Peers include ANAB, AVTE, BOLT, ERAS, EWTX, FENC and others.
KROS has a market capitalization of $429.91M, compared to an average peer market cap of $1.52B. KROS is notably smaller than its average peer.
